End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
323 TWD | -1.82% | +3.19% | +18.75% |
Sales 2024 * | 18.82B 578M | Sales 2025 * | 21.2B 651M | Capitalization | 85.42B 2.62B |
---|---|---|---|---|---|
Net income 2024 * | 4.84B 149M | Net income 2025 * | 6.2B 190M | EV / Sales 2024 * | 4.84 x |
Net Debt 2024 * | 5.71B 175M | Net Debt 2025 * | 1.56B 47.98M | EV / Sales 2025 * | 4.1 x |
P/E ratio 2024 * |
17.5
x | P/E ratio 2025 * |
14.3
x | Employees | 1,099 |
Yield 2024 * |
1.66% | Yield 2025 * |
2.32% | Free-Float | 48.47% |
Latest transcript on Lotus Pharmaceutical Co., Ltd.
1 day | -1.82% | ||
1 week | +3.19% | ||
Current month | +6.25% | ||
1 month | +6.25% | ||
3 months | +16.61% | ||
6 months | +27.17% | ||
Current year | +18.75% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 14-09-28 | |
I ling Tian
DFI | Director of Finance/CFO | - | 16-10-31 |
Ying Ming Yue
COO | Chief Operating Officer | - | 22-11-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 60 | 14-08-10 | |
Director/Board Member | 61 | 15-04-22 | |
Árni Harðarson
BRD | Director/Board Member | 57 | 14-08-10 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 4 M€ | -4.41% | - | |
0.01% | 117 M€ | +0.59% | - | |
0.00% | 34 M€ | +1.85% | - | |
0.00% | 7 M€ | +0.11% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-29 | 323 | -1.82% | 3 469 867 |
24-04-29 | 329 | +4.61% | 5,467,526 |
24-04-26 | 314.5 | +0.80% | 3,089,031 |
24-04-25 | 312 | -2.65% | 4,600,753 |
24-04-24 | 320.5 | 0.00% | 6,155,348 |
End-of-day quote Taiwan S.E., April 29, 2024
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.75% | 2.67B | |
+33.74% | 664B | |
+29.29% | 567B | |
-7.12% | 354B | |
+19.18% | 330B | |
+4.72% | 286B | |
+13.79% | 234B | |
+4.93% | 199B | |
-9.78% | 196B | |
-4.59% | 148B |
- Stock Market
- Equities
- 1795 Stock